KANNAN RAJ 4
4 · AERIE PHARMACEUTICALS INC · Filed Mar 22, 2022
Insider Transaction Report
Form 4
KANNAN RAJ
DirectorChief Executive Officer
Transactions
- Award
Stock Option (right to buy)
2022-03-18+197,239→ 197,239 totalExercise: $8.80Exp: 2032-03-18→ Common Stock (197,239 underlying)
Footnotes (1)
- [F1]This Option was granted under the Aerie Pharmaceuticals, Inc. Amended and Restated Inducement Award Plan and is scheduled to vest, subject to the reporting person's continued employment with the issuer through the applicable vesting date, as to 25% of the underlying shares on March 18, 2023 and as to the remaining underlying shares in substantially equal installments on each of the subsequent 36 monthly anniversaries of March 18, 2023.